In addition, HDAC inhibitors upregulate PD-1 or PD-L1 expression on tumor or immune cells, sensitizing tumor-bearing mice to anti-PD-1/PD-L1 antibodies [143]. The gene discussed is HDAC9; the disease is neoplasm.